Key result
Non-coding RNAs regulate key post-MI remodeling pathways, emerging as potential therapeutic targets.
Answers are grounded in this paper and cite their sources.
Acute myocardial infarction (AMI) is one of the most common cardiovascular diseases that leads to high mortality and morbidity globally. Various therapeutic targets for AMI have been investigated in recent years, including the non-coding RNAs (ncRNAs). NcRNAs, a class of RNA molecules that typically do not code proteins, are divided into several subgroups. Among them, microRNAs (miRNAs) are widely studied for their modulation of several pathological aspects of AMI, including cardiomyocyte apoptosis, inflammation, angiogenesis and fibrosis. It has emerged that long ncRNAs (lncRNAs) and circular RNAs (circRNAs) also regulate these processes via interesting mechanisms. However, the regulatory functions of ncRNAs in AMI and their underlying functional mechanisms have not been systematically described. In this review, we summarize the recent findings involving ncRNA actions in AMI and briefly describe the novel mechanisms of these ncRNAs, highlighting their potential application as therapeutic targets in AMI.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2016) conducted a review in Acute myocardial infarction. Non-coding RNAs (miRNAs, lncRNAs, circRNAs) was evaluated. Non-coding RNAs (miRNAs, lncRNAs, and circRNAs) regulate cardiomyocyte apoptosis, inflammation, angiogenesis, and fibrosis, serving as potential therapeutic targets in acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: